Immunizations, immunology, and autism

Seminars in Pediatric Neurology

Volumn 11, Issue 3, 2004, Pages 214-217

  Chez, Michael G ^a,b   Chin, Kathleen ^a   Hung, Paul C ^a  

^a IL   (United States)

^b Libertyville IL 60048 ^*  (United States)

Author keywords

autism; autoimmune; immunizations; measles; MMR; rubella; thimerisol

Indexed keywords

IMMUNOGLOBULIN; MEASLES MUMPS VARICELLA VACCINE; STEROID; THIOMERSAL; UNCLASSIFIED DRUG; VACCINE;

AUTISM; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL FEATURE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; GENETIC RISK; HEALTH EDUCATION; HUMAN; IMMUNIZATION; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; PARENTAL BEHAVIOR; REVIEW; RISK ASSESSMENT; RISK FACTOR; SAFETY; TREATMENT OUTCOME;

AUTISTIC DISORDER; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; MEASLES-MUMPS-RUBELLA VACCINE; PRESERVATIVES, PHARMACEUTICAL; RISK FACTORS; THIMEROSAL;

EID: 6344254734     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2004.07.005     Document Type: Review

References (54)

1. V.A.A. Jansen, N. Stollenwerk, H.J. Jensen Measles outbreaks in a population with declining vaccine uptake Science 301 2003 804
2. A.J. Wakefield, S.H. Murch, A. Anthony Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children Lancet 351 1998 637 641
3. J.J. O'Leary, V. Uhlmann, A.J. Wakefield Measles virus and autism [letter] Lancet 356 2000 772
4. N.A. Halsey, S.L. Hyman Conference Writing Panel Measles-mumps-rubella vaccine and autistic spectrum disorder Report from the New Challenges in Childhood Immunizations Conference Convened in Oak Brook, IL, June 12-3, 2000 Pediatrics 107 2001 E84
5. E. Fombonne, S. Chakrabarti No evidence for a new variant of measles-mumps-rubella-induced autism Pediatrics 108 2001 E58
6. L. Dales, S.J. Hammer, N.J. Smith Time trends in autism and in MMR immunization coverage in California JAMA 285 2001 1183 1185
7. C.P. Farrington, E. Miller, B. Taylor MMR and autism further evidence against a causal association Vaccine 19 2001 3632 3635
8. J.A. Kaye, M. del Mar Melero-Montes, H. Jick Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners A time trend analysis BMJ 322 2001 460 463
9. N. Andrews, E. Miller, B. Taylor Recall bias, MMR, and autism Arch Dis Child 87 2002 493 494
10. B. Taylor, E. Miller, R. Lingam Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism population study BMJ 324 2002 393 396
11. F. DeStefano, W.W. Thompson MMR vaccination and autism Is there a link? Expert Opin Drug Safety 1 2002 115 120
12. California Department of Developmental Services: Autistic Spectrum Disorders: Changes in the California Caseload. An Update, 1999 Through 2002. Sacramento, CA, California Health and Human Services Agency, April 2003
13. K.M. Madsen, A. Hviid, M. Vestergaard A population-based study of measles, mumps, and rubella vaccination and autism N Engl J Med 347 2002 1477 1482
14. D.A. Elliman, H.E. Bedford Measles, mumps and rubella vaccine, autism and inflammatory bowel disease Advising concerned parents Paediatr Drugs 4 2002 631 635
15. H. Takahashi, S. Suzumura, F. Shirakizawa An epidemiological study on Japanese autism concerning routine childhood immunization history Jpn J Infect Dis 56 2003 114 117
16. F. DeStefano, T.K. Bhasin, W.W. Thompson Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects A population-based study in metropolitan Atlanta Pediatrics 113 2004 259 266
17. D.A. Geier, M.R. Geier A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism Med Sci Monitor 10 2004 PI33 PI39
18. Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine. Immunization Safety Review: Vaccines and Autism 2004 National Academy Press Washington, DC
19. A. Hviid, M. Stellfeld, J. Wohlfahrt Association between thimerosal-containing vaccine and autism JAMA 290 2003 1763 1766
20. K.M. Madsen, M.B. Lauritsen, C.B. Pedersen Thimerosal and the occurrence of autism Negative ecological evidence from Danish population-based data Pediatrics 112 2003 604 606
21. D.A. Geier, M.R. Geier An assessment of the impact of thimerosal on childhood neurodevelopmental disorders Pediatr Rehabil 6 2003 97 102
22. M.R. Geier, D.A. Geier Neurodevelopmental disorders after thimerosal-containing vaccines A brief communication Exp Biol Med (Maywood) 228 2003 660 664
23. G.J. Myers, P.W. Davidson, C. Cox Prenatal methymercury exposure from ocean fish consumption in the Seychelles child development study Lancet 361 2003 1686 1692
24. Food and Drug Administration: Thimerosal content in some currently manufactured U.S. licensed vaccines (table); available at http://www.cdc.gov/ nip/vacsafe/concerns/thimersol/default.htm (accessed September 2004)
25. A.J. Wakefield, J.M. Puleston, S.M. Montgomery The concept of entero-colonic encephalopathy, autism and opioid receptor ligands Aliment Pharmacol Ther 16 2000 663 674
26. M. Hornig, D. Chian, W.I. Lipkin Neurotoxic effects of postnatal thimerosal are mouse strain dependent Mol Psychiatry 9 2004 833 845
27. S. Murch Separating inflammation from speculation in autism Lancet 362 2003 14 98
28. S.H. Murch, A. Anthony, D.H. Casson Retraction of an interpretation [commentary] Lancet 363 2004 750
29. A. Makela, J.P. Nuorti, H. Peltola Neurologic disorders after measles-mumps-rubella vaccination Pediatrics 110 2002 957 963
30. V.K. Singh, S.X. Lin, E. Newell Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism J Biomed Sci 9 2002 359 364
31. R.P. Warren, V.K. Singh, P. Cole Increased frequency of the null allele at the complement C4B locus in autism Clin Exp Immunol 83 1991 438 440
32. A.M. Comi, A.W. Zimmerman, V.H. Frye Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism J Child Neurol 14 1999 388 394
33. R.P. Warren, N.C. Margaretten, N.C. Pace Immune abnormalities in patients with autism J Autism Dev Disord 16 1986 189 197
34. E.G. Stubbs, M.L. Crawford Depressed lymphocyte responsiveness in autistic children J Autism Child Schizophr 7 1977 49 55
35. V.K. Singh, S.X. Lin, V.C. Yang Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism Clin Immunol Immunopathol 89 1998 105 108
36. V.K. Singh, R.P. Warren, J.D. Odell Antibodies to myelin basic protein in children with autistic behavior Brain Behav Immun 7 1993 97 103
37. S. Gupta, S. Aggarwal, C. Heads Brief report: Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics J Autism Dev Disord 26 1996 439 452
38. R.D. Todd, J.M. Hickok, G.M. Anderson Antibrain antibodies in infantile autism Biol Psychol 23 1988 644 647
39. A.V. Plioplys, A. Greaves, K. Kazemi Immunoglobulin reactivity in autism and Rett's syndrome Dev Brain Dys 7 1994 12 16
40. A.M. Connolly, A. Pestronk, S. Mehta Serum autoantibodies in childhood opsoclonus-myoclonus syndrome An analysis of antigenic targets in neural tissues J Pediatr 130 1997 878 884
41. V.K. Singh, J.F. Cheng Immunoreactive S100 proteins of blood immunocytes and brain cells J Neuroimmunol 64 1996 135 139
42. R.P. Warren, A. Foster, N.C. Margaretten Reduced natural killer cell activity in autism J Am Acad Child Adolesc Psychiatry 26 1987 333 335
43. R.P. Warren, J.D. Odell, W.L. Warren Is decreased blood plasma concentration of the complement C4B protein associated with attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 34 1995 1009 1014
44. R.P. Warren, J. Yonk, R.W. Burger DR-positive T cells in autism Association with decreased plasma levels of the complement C4B protein Neuropsychobiology 31 1995 53 57
45. R.P. Warren, L.J. Yonk, R.A. Burger Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism Immunol Invest 19 1990 245 251
46. A.M. Connelly, M.G. Chez, A. Pestronk Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders J Pediatr 134 1999 607 613
47. M.G. Chez, A.M. Connolly, C. Nowinski The presence of autoantibodies in idiopathic/acquired versus genetic variants of pediatric epilepsy Epilepsia 41 Suppl 2000 183
48. K.B. Nelson, J.K. Grether, L.A. Croen Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation Ann Neurol 49 2001 597 606
49. L.A. Snider, S.E. Swedo Pediatric obsessive-compulsive disorder JAMA 284 2000 3104 3106
50. H.S. Singer, C. Loiselle PANDAS A commentary J Psychosom Res 55 2003 31 39
51. M.G. Chez, C. Buchanan, M. Field-Chez Treatment of electroencephalographic epileptiform activity on overnight EEG Studies in children with pervasive developmental disorder or autism Defining similiarities to the Landau-Kleffner syndrome J Dev Learn Disord 2 1998 217 229
52. G.A. Stefanatos, W. Grover, E. Geller Case study Corticosteroid treatment of language regression in pervasive developmental disorder J Am Acad Child Adolesc Psychiatry 34 1995 1107 1111
53. S. Gupta Immunological treatments for autism J Autism Dev Disord 30 2000 475 479
54. A.V. Plioplys Intravenous immunoglobulin treatment of children with autism J Child Neurol 13 1999 79 82